Bioverativ logo

Bioverativ

Bioverativ, a global biopharmaceutical company focused on hemophilia and rare blood disorders.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”BIVV” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.bioverativ.com
Founded2016
Disease Focus
Development Stage
STOCK CODENASDAQ: BIVV
Address
225 Second Avenue, MA 02451
Waltham
United States
Email
Contact Number
+1 781-663-4400

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/bioverativ” connections=”true” suffix=””]